Malawi, Rwanda, Laos and Zambia Have Received COVID-19 Oral Treatments

The COVID Treatment Quick Start Consortium announced today that the governments of Zambia, Laos, Malawi and Rwanda have received shipments of PAXLOVID™ (nirmatrelvir/ritonavir), Pfizer’s COVID-19 oral treatment. Zambia was the first country to receive the treatment through the consortium, with an initial shipment of 1,000 courses of PAXLOVID™ reaching Lusaka in late December 2022 as…

WHO’s working definitions and tracking system for SARS-CoV-2 variants of concern and variants of interest

WHO has updated its tracking system and working definitions for variants of SARS-CoV-2, the virus that causes COVID-19, to better correspond to the current global variant landscape, to independently evaluate Omicron sublineages in circulation, and classify new variants more clearly when required. SARS-CoV-2 continues to evolve. Since the beginning of the COVID-19 pandemic, multiple variants…

Education Cannot Wait Renews Multi-Year Resilience Programme in Uganda with US$25 Million in Catalytic Funding Investment; Calls on Donors to Scale-Up Support

In response to Africa’s largest refugee crisis, Education Cannot Wait (ECW) today announced US$25 million in catalytic funding to expand the Fund’s Multi-Year Resilience Programme, which continues to bridge the humanitarian-development nexus in Uganda. Total ECW funding in Uganda now tops US$75 million. The extended three-year programme will be delivered by Save the Children and…

Lacor Hospital Operates on 30 Children with Anorectal Malformation

St Mary`s Hospital Lacor in Gulu City has successfully operated on and treated thirty children with Anorectal malformation, a birth defect where a child presents without an anus or narrow anal opening.  Such children experience chronic constipation or difficulty in passing stool among others. The Acholi community widely attributes the condition to ‘’evil spirits’’ or bad omens…

Contracting a respiratory infection in early childhood associated with a higher risk of dying from the same as an adult, Lancet study finds

This first-of-its-kind study which spans eight decades suggests that, although the overall number of premature deaths from respiratory disease was small, people who had a LRTI, such as bronchitis or pneumonia, by the age of two were 93% more likely to die prematurely from respiratory disease as adults, regardless of socioeconomic background or smoking status.…